Hatch-Waxman Safe Harbor: Post-Approval Activity Update
The U.S. Supreme Court has twice addressed the scope of the safe harbor provision of the Hatch-Waxman Act (Eli Lilly & Co. v. Medtronic Inc., 496 U.S. 661 (1990) and Merck...To view the full article, register now.
Already a subscriber? Click here to view full article